Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$13.58 - $17.36 $193,610 - $247,501
14,257 New
14,257 $224,000
Q3 2023

Nov 14, 2023

BUY
$12.46 - $15.48 $132,711 - $164,877
10,651 New
10,651 $135,000
Q3 2022

Nov 14, 2022

SELL
$12.38 - $20.23 $102,407 - $167,342
-8,272 Reduced 43.58%
10,708 $198,000
Q2 2022

Aug 12, 2022

BUY
$9.11 - $13.98 $172,907 - $265,340
18,980 New
18,980 $250,000
Q1 2020

May 13, 2020

SELL
$33.63 - $69.4 $121,068 - $249,840
-3,600 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$31.7 - $69.93 $114,120 - $251,748
3,600 New
3,600 $224,000
Q3 2019

Nov 14, 2019

SELL
$19.95 - $38.85 $183,021 - $356,409
-9,174 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$21.05 - $26.21 $193,112 - $240,450
9,174 New
9,174 $207,000

Others Institutions Holding DCPH

About Deciphera Pharmaceuticals, Inc.


  • Ticker DCPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,822,100
  • Description
  • Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...
More about DCPH
Track This Portfolio

Track Dynamic Technology Lab Private LTD Portfolio

Follow Dynamic Technology Lab Private LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

News

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.